Novo Nordisk A/S
NONOF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $15,655,000 | $14,392,000 | $12,653,000 | $10,720,000 |
| Short-Term Investments | $10,653,000 | $15,838,000 | $10,921,000 | $6,765,000 |
| Receivables | $87,414,000 | $75,261,000 | $57,505,000 | $46,799,000 |
| Inventory | $40,849,000 | $31,811,000 | $24,388,000 | $19,621,000 |
| Other Curr. Assets | $6,326,000 | $2,344,000 | $2,727,000 | $1,690,000 |
| Total Curr. Assets | $160,897,000 | $139,646,000 | $108,194,000 | $85,595,000 |
| Property Plant & Equip (Net) | $162,488,000 | $90,961,000 | $66,671,000 | $55,362,000 |
| Goodwill | $20,064,000 | $4,464,000 | $4,615,000 | $4,346,000 |
| Intangibles | $91,026,000 | $55,942,000 | $46,324,000 | $38,825,000 |
| Long-Term Investments | $2,677,000 | $1,663,000 | $1,343,000 | $1,441,000 |
| Tax Assets | $24,627,000 | $20,380,000 | $13,427,000 | $8,672,000 |
| Other NC Assets | $4,016,000 | $1,430,000 | $206,000 | $267,000 |
| Total NC Assets | $304,898,000 | $174,840,000 | $133,063,000 | $108,913,000 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $465,795,000 | $314,486,000 | $241,257,000 | $194,508,000 |
| Liabilities | – | – | – | – |
| Payables | $28,846,000 | $25,606,000 | $15,587,000 | $8,870,000 |
| Short-Term Debt | $13,113,000 | $6,478,000 | $1,466,000 | $13,684,000 |
| Tax Payable | $9,716,000 | $7,116,000 | $7,091,000 | $3,658,000 |
| Deferred Revenue | $0 | $0 | $0 | $55,178,000 |
| Other Curr. Liab. | $165,853,000 | $137,571,000 | $103,887,000 | -$37,052,000 |
| Total Curr. Liab. | $217,528,000 | $169,655,000 | $120,940,000 | $99,516,000 |
| LT Debt | $89,674,000 | $20,528,000 | $24,318,000 | $12,961,000 |
| Deferred Rev, NC | $0 | $0 | $0 | $5,654,000 |
| Deferred Tax Liab, NC | $5,426,000 | $10,162,000 | $7,061,000 | $5,271,000 |
| Other NC Liab. | $9,681,000 | $7,580,000 | $5,452,000 | $360,000 |
| Total NC Liab. | $104,781,000 | $38,270,000 | $36,831,000 | $24,246,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $6,766,000 | $5,726,000 | $4,529,000 | $4,129,000 |
| Total Liabilities | $322,309,000 | $207,925,000 | $157,771,000 | $123,762,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $446,000 | $451,000 | $456,000 | $462,000 |
| Retained Earnings | $144,448,000 | $104,839,000 | $80,587,000 | $72,004,000 |
| AOCI | -$1,406,000 | $1,276,000 | $2,449,000 | -$1,714,000 |
| Other Equity | -$2,000 | -$5,000 | -$6,000 | -$6,000 |
| Total Equity | $143,486,000 | $106,561,000 | $83,486,000 | $70,746,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $465,795,000 | $314,486,000 | $241,257,000 | $194,508,000 |
| Net Debt | $87,132,000 | $12,614,000 | $13,131,000 | $15,925,000 |